硫酸氢氯吡格雷联合阿司匹林治疗老年冠心病对凝血指标、血小板聚集率影响.docVIP

硫酸氢氯吡格雷联合阿司匹林治疗老年冠心病对凝血指标、血小板聚集率影响.doc

  1. 1、本文档共10页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
硫酸氢氯吡格雷联合阿司匹林治疗老年冠心病对凝血指标、血小板聚集率影响

硫酸氢氯吡格雷联合阿司匹林治疗老年冠心病对凝血指标、血小板聚集率影响   [摘要]目的 探讨硫酸氢氯吡格雷联合阿司匹林肠溶片对老年冠心病患者凝血指标及血小板聚集率情况的影响。方法 选择80例老年冠心病患者作为观察对象,以随机数字表法将患者分为阿司匹林组及联合组,每组40例,阿司匹林组接受阿司匹林肠溶片抗凝治疗,联合组接受硫酸氢氯吡格雷联合阿司匹林肠溶片抗凝治疗,分析两组治疗过程中凝血指标及血小板聚集率变化情况。结果 两组治疗过程中,PT、APTT及INR呈升高趋势,FIB及PAR呈下降趋势(P0.05),而在治疗14d及治疗28d时,联合组PT、APTT及INR高于阿司匹林组,FIB及PAR低于阿司匹林组(P0.05)。结论 在老年冠心病的治疗中硫酸氢氯吡格雷联合阿司匹林肠溶片可在不增加药物不良反应发生率的同时,有效的改善患者的凝血及血小板聚集率指标 [关键词] 硫酸氢氯吡格雷;阿司匹林肠溶片;老年;冠心病;凝血指标;血小板聚集率 [中图分类号] R543.3 [文献标识码] A [文章编号] 2095-0616(2017)06-23-04 [Abstract] Objective To explore the effect of clopidogrel bisulfate combined with aspirin on blood coagulation and platelet aggregation in elderly patients with coronary heart disease. Methods 80 elderly patients with coronary heart disease were selected as the observation objects. According to random number table method, they were divided into aspirin group and combination group with 40 cases in each. Patients in aspirin group were treated with aspirin enteric-coated tablets anticoagulant therapy, and patients in combination group were treated with clopidogrel bisulfate combined with aspirin. Changes of coagulation index and platelet aggregation rate during treatment of the two groups were analyzed. Results During the treatment, PT, APTT and INR of the two groups showed an increasing trend, FIB and PAR showed a downward trend(P0.05) when compared on beginning the group and on the 7d after treatment. However, PT, APTT and INR in the combination group were higher than those in the aspirin group in the treatment of 14d and 28d, and the FIB and PAR were lower than those in the aspirin group(P0.05). Conclusion Clopidogrel bisulfate combined with aspirin on blood coagulation and platelet aggregation in elderly patients with coronary heart disease can not only increase the incidence of adverse drug reactions, but also improve the coagulation and platelet aggregation rate. [Key words] Clopidogrel bisulfate; Aspirin enteric-coated tablets; Old age; Coronary heart disease; Coagulation index; Pla

文档评论(0)

linsspace + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档